ProCE Banner Activity

Applying the Clinical Rationale for Inhibiting the Complement-Mediated Hemolysis in CAD

Slideset

Downloadable slideset with the latest clinical data for targeting the complement pathway as a successful strategy for the management of patients with CAD, including clinical data updates and expanded indication for anti-C1 targeted agent sutimlimab.

Released: December 01, 2023

Share

Faculty

Catherine M. Broome

Catherine M. Broome, MD

Professor of Medicine
MedStar Georgetown University Hospital
Lombardi Cancer Center
Washington, DC

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi